Identification of intermediate risk breast cancer patients with1–3 positive lymph nodes and excellent survival after tamoxifen as only systemic adjuvant therapy by use of markers of proliferation and apoptosis

Barbro Linderholm,S Linder,Lars-Gunnar Arnesson,Olle Stål

Identification of intermediate risk breast cancer patients with1–3 positive lymph nodes and excellent survival after tamoxifen as only systemic adjuvant therapy by use of markers of proliferation and apoptosis

2013

Barbro Linderholm
S Linder
Lars-Gunnar Arnesson
Olle Stål

Background: According to current guidelines, patients with primary breast cancer and 1-3 lymph node metastases will in general be offered adjuvant chemotherapy. less thanbrgreater than less thanbrg ...

Keywords:

Gynecology
Breast cancer
General surgery
Adjuvant therapy
Adjuvant
Lymph
Tamoxifen
Lymph node
Apoptosis
Medicine
Chemotherapy
Oncology
intermediate risk
Internal medicine
adjuvant chemotherapy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations